Biodelivery Sciences International EBIT

Biodelivery Sciences International (BDSI) currently reports a EBIT of $37M as of December 2021. That compares with $33M in the prior-year period — up 12.6% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Biodelivery Sciences International's EBIT history and peer comparisons.

Biodelivery Sciences International's EBIT increased from $33M to $37M — a 12.6% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodelivery Sciences International's EBIT of $37M is lower than the Healthcare sector average of $23B. That is roughly 99.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Biodelivery Sciences International reported $37M in EBIT as of December 2021. That compares with $33M in the prior-year period — up 12.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $37M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Biodelivery Sciences International, and consider following BDSI for alerts when major investors trade the stock.